Chemoenzymatic Synthesis of Cholesterol-g-Poly(amine-co-ester) Amphiphilic Copolymer as a Carrier for miR-23b Delivery

被引:16
作者
Chen, Jiawen [1 ]
Jiang, Wei [2 ]
Han, Haobo [1 ]
Yang, Jiebing [1 ]
Chen, Wenqi [1 ]
Wang, Yudi [1 ]
Tang, Jun [2 ]
Li, Quanshun [1 ]
机构
[1] Jilin Univ, Sch Life Sci, Coll Chem, Key Lab Mol Enzymol & Engn,Minist Educ, Changchun 130012, Peoples R China
[2] Jilin Univ, Dept Polymer Sci, Coll Chem, Changchun 130012, Peoples R China
关键词
GENE DELIVERY; POLY(AMINE-CO-ESTER) TERPOLYMERS; CANCER; METASTASIS; VECTORS; NANOPARTICLES; MICELLES; LIBRARY; G1;
D O I
10.1021/acsmacrolett.7b00211
中图分类号
O63 [高分子化学(高聚物)];
学科分类号
070305 ; 080501 ; 081704 ;
摘要
The lipase-catalyzed polymerization of N-methyldiethanolamine, diethyl sebacate and w-pentadecanolide was performed to construct a cationic poly(amine-co-ester), and a hydrophobic N-(2-bromoethyl)carbamoyl cholesterol was then grafted onto its main chain through a quaternization reaction to prepare the amphiphilic copolymer Chol-g-PMSC-PPDL. The copolymer efficiently bound and condensed miR-23b to form stable nanocomplexes, which showed favorable cellular uptake and miR-23b transfection efficacy due to the introduction of the hydrophobic segment. After miR-23b delivery, an obvious inhibition of cell proliferation could be induced, which was attributed to the induction of cell apoptosis and cell cycle arrest. Moreover, the carrier-mediated miR-23b delivery could inhibit the migration and invasion of tumor cells. Overall, the work provides a novel chemoenzymatic strategy for constructing biodegradable and biocompatible poly(amine-co-ester) derivatives, which are promising carriers for oligonucleotide delivery to achieve tumor gene therapy.
引用
收藏
页码:523 / 528
页数:6
相关论文
共 32 条
[1]   Intracellular delivery of the PTEN protein using cationic lipidoids for cancer therapy [J].
Altinoglu, Sarah A. ;
Wang, Ming ;
Li, Kathleen Q. ;
Li, Yuyang ;
Xu, Qiaobing .
BIOMATERIALS SCIENCE, 2016, 4 (12) :1773-1780
[2]   Structure/property studies of polymeric gene delivery using a library of poly(β-amino esters) [J].
Anderson, DG ;
Akinc, A ;
Hossain, N ;
Langer, R .
MOLECULAR THERAPY, 2005, 11 (03) :426-434
[3]   miRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents [J].
Baumann, Volker ;
Winkler, Johannes .
FUTURE MEDICINAL CHEMISTRY, 2014, 6 (17) :1967-1984
[4]   Advancing Polymeric Delivery Systems Amidst a Nucleic Acid Therapy Renaissance [J].
Burke, Paul A. ;
Pun, Suzie H. ;
Reineke, Theresa M. .
ACS MACRO LETTERS, 2013, 2 (10) :928-934
[5]   microRNA-23b suppresses epithelial-mesenchymal transition (EMT) and metastasis in hepatocellular carcinoma via targeting Pyk2 [J].
Cao, Jie ;
Liu, Jinkai ;
Long, Jianyun ;
Fu, Jing ;
Huang, Liang ;
Li, Jing ;
Liu, Caifeng ;
Zhang, Xianghua ;
Yan, Yiqun .
BIOMEDICINE & PHARMACOTHERAPY, 2017, 89 :642-650
[6]   Enzymatic PEGylated Poly(lactone-co-β-amino ester) Nanoparticles as Biodegradable, Biocompatible and Stable Vectors for Gene Delivery [J].
Chen, Ya ;
Li, Yingqin ;
Gao, Jinbiao ;
Cao, Zhong ;
Jiang, Qing ;
Liu, Jie ;
Jiang, Zhaozhong .
ACS APPLIED MATERIALS & INTERFACES, 2016, 8 (01) :490-501
[7]   The BCL-2 protein family, BH3-mimetics and cancer therapy [J].
Delbridge, A. R. D. ;
Strasser, A. .
CELL DEATH AND DIFFERENTIATION, 2015, 22 (07) :1071-1080
[8]   The microRNA-23b/27b/24-1 cluster is a disease progression marker and tumor suppressor in prostate cancer [J].
Goto, Yusuke ;
Kojima, Satoko ;
Nishikawa, Rika ;
Enokida, Hideki ;
Chiyomaru, Takeshi ;
Kinoshita, Takashi ;
Nakagawa, Masayuki ;
Naya, Yukio ;
Ichikawa, Tomohiko ;
Seki, Naohiko .
ONCOTARGET, 2014, 5 (17) :7748-7759
[9]   A combinatorial polymer library approach yields insight into nonviral gene delivery [J].
Green, Jordan J. ;
Langer, Robert ;
Anderson, Daniel G. .
ACCOUNTS OF CHEMICAL RESEARCH, 2008, 41 (06) :749-759
[10]   Clinical and biological significance of miR-23b and miR-193a in human hepatocellular carcinoma [J].
Grossi, Ilaria ;
Arici, Bruna ;
Portolani, Nazario ;
De Petro, Giuseppina ;
Salvi, Alessandro .
ONCOTARGET, 2017, 8 (04) :6955-6969